Literature DB >> 26162991

Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis.

Su Luo1, Jie-Yao Li1, Li-Na Zhao2, Tao Yu3, Wa Zhong1, Zhong-Sheng Xia1, Ti-Dong Shan1, Hui Ouyang1, Hong-Sheng Yang1, Qi-Kui Chen4.   

Abstract

OBJECTIVE: Recent studies proved that patients with diabetes were at significantly higher risk of developing colorectal cancer. However, the association between diabetes mellitus and the risk of colorectal adenoma remains undefined. Thus we conducted an updated meta-analysis to identify the association between diabetes mellitus and the risk of colorectal neoplasia including adenoma and cancer.
METHODS: We conducted a search in databases including Pubmed, Web of Science, EMBASE Databases, Cochrane CENTRAL, Wanfang Data, and CNKI database. Case-control and cohort studies were included. All articles were published before January 2015 and the quality of each study was evaluated by the Newcastle-Ottawa Scale. Odds ratios (ORs) or relative risks (RRs) and its corresponding 95% confidence intervals (CIs) for each study were calculated and summary relative risk estimates with corresponding 95% CIs were generated using the random-effects model. Heterogeneity and publication bias were assessed.
RESULTS: Twenty-nine articles including ten case-control studies and nineteen cohort studies were included in this meta-analysis. In a pooled analysis of all studies, diabetes mellitus was associated with increased risk of colorectal neoplasia (RR=1.35, 95% CI=1.28-1.42). The risk increased significantly for both colorectal cancer (RR=1.37, 95% CI=1.30-1.45) and adenoma (RR=1.26, 95% CI=1.11-1.44). Subgroup analyses on study design, gender, geographical region, and type of diabetes mellitus further evidenced these findings.
CONCLUSIONS: Diabetes mellitus was associated with an increased risk of colorectal neoplasia. Not only the increased risk of colorectal cancer but also the higher risk of adenoma was identified in patients with diabetes mellitus.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26162991     DOI: 10.1016/j.clinre.2015.05.021

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  14 in total

1.  Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.

Authors:  Amy R Marks; Ralph A Pietrofesa; Christopher D Jensen; Alexis Zebrowski; Douglas A Corley; Chyke A Doubeni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-16       Impact factor: 4.254

2.  Risk of colon cancer recurrence in relation to diabetes.

Authors:  Jessica Chubak; Onchee Yu; Rebecca A Ziebell; Erin J Aiello Bowles; Andrew T Sterrett; Monica M Fujii; Jennifer M Boggs; Andrea N Burnett-Hartman; Denise M Boudreau; Lu Chen; James S Floyd; Debra P Ritzwoller; Rebecca A Hubbard
Journal:  Cancer Causes Control       Date:  2018-09-22       Impact factor: 2.506

3.  A healthy lifestyle pattern has a protective association with colorectal polyps.

Authors:  Naomi Fliss-Isakov; Revital Kariv; Muriel Webb; Dana Ivancovsky-Wajcman; Oleg Zaslavsky; Dana Margalit; Oren Shibolet; Shira Zelber-Sagi
Journal:  Eur J Clin Nutr       Date:  2019-07-30       Impact factor: 4.016

4.  Diabetes mellitus and the risk of glioma: a meta-analysis.

Authors:  Luqian Zhao; Zhiping Zheng; Ping Huang
Journal:  Oncotarget       Date:  2016-01-26

Review 5.  Diabetes-induced mechanophysiological changes in the small intestine and colon.

Authors:  Mirabella Zhao; Donghua Liao; Jingbo Zhao
Journal:  World J Diabetes       Date:  2017-06-15

Review 6.  Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.

Authors:  Fanqiang Meng; Li Song; Wenyue Wang
Journal:  J Diabetes Res       Date:  2017-02-08       Impact factor: 4.011

7.  Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies.

Authors:  Nam Hee Kim; Jung Yul Suh; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

8.  Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies.

Authors:  Nikos Papadimitriou; Marc J Gunter; Neil Murphy; Audrey Gicquiau; David Achaintre; Stefanie Brezina; Tanja Gumpenberger; Andreas Baierl; Jennifer Ose; Anne J M R Geijsen; Eline H van Roekel; Andrea Gsur; Biljana Gigic; Nina Habermann; Cornelia M Ulrich; Ellen Kampman; Matty P Weijenberg; Per Magne Ueland; Rudolf Kaaks; Verena Katzke; Vittorio Krogh; Bas Bueno-de-Mesquita; Eva Ardanaz; Ruth C Travis; Matthias B Schulze; Maria-José Sánchez; Sandra M Colorado-Yohar; Elisabete Weiderpass; Augustin Scalbert; Pekka Keski-Rahkonen
Journal:  Int J Cancer       Date:  2021-07-12       Impact factor: 7.396

9.  Diabetes Mellitus and Site-specific Colorectal Cancer Risk in Korea: A Case-control Study.

Authors:  Hyeongtaek Woo; Jeeyoo Lee; Jeonghee Lee; Ji Won Park; Sungchan Park; Jeongseon Kim; Jae Hwan Oh; Aesun Shin
Journal:  J Prev Med Public Health       Date:  2016-01

10.  Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.

Authors:  Hyeree Park; Sooyoung Cho; Hyeongtaek Woo; Sue K Park; Hai-Rim Shin; Soung-Hoon Chang; Keun-Young Yoo; Aesun Shin
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.